Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances

被引：20
|
作者：
Bauer, LA
Black, DJ
Lill, JS
Garrison, J
Raisys, VA
Hooton, TM
机构：
[1] Univ Washington, Dept Pharm, Seattle, WA 98195 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pharm Serv, Seattle, WA 98195 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 04期
关键词：
D O I：
10.1128/AAC.49.4.1649-1651.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ten healthy adults participated in a randomized, crossover drug interaction study testing procainamide only, procainamide plus levofloxacin, and procainamide plus ciprofloxacin. During levofloxacin therapy, most procainamide and N-acetylprocainamide (NAPA) pharmacokinetic parameters, including decreased renal clearances and renal clearance/creatinine clearance ratios, changed (P < 0.05). During ciprofloxacin treatment, only procainamide and NAPA renal clearances decreased significantly.
引用
收藏
页码：1649 / 1651
页数：3
相关论文
共 50 条
  • [1] KINETICS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RENAL-FAILURE
    GIBSON, TP
    ATKINSON, AJ
    MATUSIK, E
    NELSON, LD
    BRIGGS, WA
    KIDNEY INTERNATIONAL, 1977, 12 (06) : 422 - 429
  • [2] KINETICS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RENAL-FAILURE
    GIBSON, T
    ATKINSON, AJ
    MATUSIK, E
    NELSON, LD
    BRIGGS, WA
    CLINICAL RESEARCH, 1977, 25 (04): : A594 - A594
  • [3] TRIMETHOPRIM DECREASES THE RENAL CLEARANCE OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE
    VLASSES, PH
    LOTTES, SR
    CHASE, SL
    GREENSPON, AJ
    ANDRESS, E
    ROCCI, ML
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 233 - 233
  • [4] TRIMETHOPRIM INHIBITION OF THE RENAL CLEARANCE OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE
    VLASSES, PH
    KOSOGLOU, T
    CHASE, SL
    GREENSPON, AJ
    LOTTES, S
    ANDRESS, E
    FERGUSON, RK
    ROCCI, ML
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) : 1350 - 1353
  • [5] N-ACETYLPROCAINAMIDE - ACTIVE METABOLITE OF PROCAINAMIDE
    DRAYER, DE
    REIDENBERG, MM
    SEVY, RW
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1974, 146 (02): : 358 - 363
  • [6] PHARMACOKINETICS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RATS
    KAMATH, BL
    LAI, CM
    GUPTA, SD
    DURRANI, MJ
    YACOBI, A
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (03) : 299 - 302
  • [7] PLASMA-CONCENTRATIONS OF DESETHYL N-ACETYLPROCAINAMIDE IN PATIENTS TREATED WITH PROCAINAMIDE AND N-ACETYLPROCAINAMIDE
    RUO, TI
    THENOT, JP
    STEC, GP
    ATKINSON, AJ
    THERAPEUTIC DRUG MONITORING, 1981, 3 (03) : 231 - 237
  • [8] QUANTITATIVE DISPOSITION OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RAT
    SCHNECK, DW
    GROVE, K
    DEWITT, FO
    SHIROFF, RA
    HAYES, AH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1978, 204 (01): : 219 - 225
  • [9] PROCAINAMIDE AND N-ACETYLPROCAINAMIDE KINETICS IN THE RAT INVIVO
    HUANG, JC
    KONG, P
    PANG, KS
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1139 - 1139
  • [10] THE EFFECT OF RANITIDINE ON PROCAINAMIDE AND N-ACETYLPROCAINAMIDE PHARMACOKINETICS
    ROCCI, ML
    KOSOGLOU, T
    FERGUSON, RK
    VLASSES, PH
    PHARMACOTHERAPY, 1988, 8 (02): : 140 - 141
12345